Cargando…
Time to revisit the use of G-CSF after allogeneic haematopoietic cell transplantation in COVID-19 era?
The use of granulocyte colony-stimulating factor (G-CSF) in patients with haematological malignancies is associated with less febrile neutropenia episodes. But in the presence of COVID-19 infection, the administration of G-CSF is challenging as it may trigger a robust inflammatory reaction resulting...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7781165/ https://www.ncbi.nlm.nih.gov/pubmed/33398065 http://dx.doi.org/10.1038/s41416-020-01195-8 |